Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

SAB Biotherapeutics, Inc. SABS

Full chart Compare
Set alert

Price alert · SABS

All alert types
3.12 USD -0.18 (-5.45%)

At closeNov 3, 2026, 4:01 PM EST

3.12 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

3.10 Day range 3.36
2.44 52-week range 5.15
YTD
-16.58%
1 year
-4.00%

Analyst view

Price target (mean) 12.40 +297.4% upside
Target (low)
6.00
Target (mean)
12.40
Target (high)
25.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SABS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.21-1.21 – -1.21-6.39+81.1%120.00K-60.7%1
Next quarter0.000.00 – 0.000.000.0%333.33K-64.7%0
Current year-3.64-3.64 – -3.64-6.77+46.2%1.34M-39.9%1
Next year-5.01-5.01 – -5.01-3.64-37.6%800.00K-40.5%1

Upgrades and downgrades

The latest rating changes

SABS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 7, 2024Chardan CapitalMaintainedBuyBuy
Oct 9, 2024Craig-HallumInitiated—Buy
Sep 12, 2024OppenheimerReiteratedOutperformOutperform
Sep 9, 2024Chardan CapitalMaintainedBuyBuy
Aug 28, 2024OppenheimerInitiated—Outperform
Aug 12, 2024Chardan CapitalMaintainedBuyBuy
Aug 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 7, 2024Brookline CapitalInitiated—Buy
May 21, 2024Chardan CapitalMaintainedBuyBuy
May 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 16, 2024Chardan CapitalMaintainedBuyBuy
Apr 2, 2024Chardan CapitalMaintainedBuyBuy
Apr 2, 2024HC Wainwright & Co.MaintainedBuyBuy
Jan 8, 2024HC Wainwright & Co.ReiteratedBuyBuy